Voyager Therapeutics, Inc. announced the appointment of Catherine J. Mackey, Ph.D. to its Board of Directors. Dr. Mackey is a seasoned life science executive with more than thirty years of operational experience highlighted by her tenure as Senior Vice President, Global Research & Development, for Pfizer, Inc. During her tenure at Pfizer, Dr. Mackey led La Jolla Labs where she oversaw more than 1,000 staff on a one-million square foot campus, delivering a steady-state pipeline of more than two dozen development compounds. Prior to her role at Pfizer La Jolla, Dr. Mackey led Strategic Alliances at its R&D headquarters, where she gained extensive experience with both corporate and academic partnerships in the U.S. and global markets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.4 USD | +3.19% | +2.07% | -0.47% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.47% | 457M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics Appoints Catherine J. Mackey, Ph.D. to Its Board of Directors